三星生物製劑產品碳足跡系統獲獨立驗證
This validation is crucial for Samsung Biologics' clients, particularly those operating within or exporting to regions with stringent environmental regulations and growing consumer demand for sustainable products.
Independent validation of Product Carbon Footprint system for enhanced climate transparency.
三星生物制剂已获得其产品碳足迹（PCF）系统的独立验证，彰显了其对气候透明度的承诺。该验证是通过与外部专家合作实现的，使公司能够为客户提供其产品的准确碳足迹数据。此举支持生物制药行业内可持续供应链的管理。
This validation is crucial for Samsung Biologics' clients, particularly those operating within or exporting to regions with stringent environmental regulations and growing consumer demand for sustainable products. It enables them to accurately assess and report the environmental impact of their biologics, facilitating greener supply chain decisions and potentially offering a competitive advantage in the APAC market. The company's proactive approach to carbon accounting sets a benchmark for the industry.
As a leading biopharmaceutical CDMO in APAC, Samsung Biologics' commitment to climate transparency through validated carbon footprinting directly impacts its regional clients and partners. This initiative aligns with growing ESG expectations across Asia, influencing supply chain sustainability and corporate responsibility standards within the sector.
Where this signal fits in the broader landscape.
https://samsungbiologics.com/media/newsroom/press-releases/samsung-biologics-leads-climate-transparency-with-independent-validation-of-product-carbon-footprint-system
Read Full SourceGet curated intelligence delivered to your inbox. No spam, unsubscribe anytime.
Sign in to save notes on signals.
登录